Cited Peptide Research

The Honest Source For
Peptide Science.

Structured scientific reference across peptides, mechanisms, and evidence — with editorial clarity for clinicians, formulators, and researchers.

Popular:GHK-CuBPC-157TB-500SermorelinCollagen synthesis
39Peptides
21On Watchlist
88Verified References
Mostly preclinical/lowEvidence

Research Statistics

Validated

39

Peptides

Verified, sourced entries

Tracked

21

On Watchlist

Tracked — insufficient evidence

Verified

88

Verified References

Unique PMIDs / DOIs

Honest

Mostly preclinical/low

Evidence

14 preclinical · 20 low · 3 moderate · 2 high

39 validated entries + 21 on the watchlist →

Cited Connections

Knowledge Graph

A living network of peptide science — peptides, biology, mechanisms, growth factors, and research, connected.

Featured Peptides

High-interest peptide entries

Curated entries with concise scientific definitions.

Copper Tripeptide-1

Copper Tripeptide-1 is a naturally occurring copper peptide complex (GHK-Cu). In laboratory and cell studies, GHK-Cu has been examined for proposed roles in collagen and elastin synthesis, the activity of collagen-degrading enzymes, and antioxidant activity. It is one of the more extensively studied peptides in skin-aging and firmness research.

Open entry →

BPC-157

BPC-157 is a synthetic pentadecapeptide based on a sequence reported in human gastric juice. Published research is largely preclinical (in vitro and animal models); studies indicate possible roles in soft-tissue and gastrointestinal repair. It is a research chemical and is not approved for human use. As of June 2026 it sits in a regulatory gray zone: it was removed from the FDA 503A Category 2 bulk-substances list in April 2026 but not added to Category 1, and it remains not FDA-approved.

Open entry →

TB-500 (Thymosin Beta-4)

TB-500 refers to a synthetic peptide related to thymosin beta-4 (Tβ4), a naturally occurring regenerative peptide. Most published evidence concerns Tβ4 in preclinical (cell and animal) models of tissue repair. TB-500 is sold as a research chemical and is not approved for human use. As of June 2026 it sits in a regulatory gray zone: thymosin beta-4 / TB-500 was removed from the FDA 503A Category 2 bulk-substances list in April 2026 but not added to Category 1, and it remains not FDA-approved; it is under FDA PCAC review (July 2026).

Open entry →

Acetyl Hexapeptide-8

Acetyl hexapeptide-8 (Argireline) is a synthetic peptide used in cosmetics and marketed for the appearance of expression lines. Ex vivo studies indicate limited skin penetration, and the cited human improvement was reported using a microneedle patch combined with other actives rather than topical application alone.

Open entry →

Matrixyl 3000

Matrixyl 3000 is a cosmetic peptide blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. A cited 12-week human study of a multi-component formula containing both peptides reported measured skin improvements; because the formula included additional actives, effects cannot be attributed to the peptide blend alone.

Open entry →

Oligopeptide-1 (EGF)

Oligopeptide-1 is the cosmetic INCI name for human epidermal growth factor (EGF), a signaling protein used in some topical skincare products. Human and review evidence describes effects on skin thickness and appearance, but a systematic review cautions that controlled evidence remains limited.

Open entry →

Research Philosophy

Evidence over marketing

This encyclopedia prioritizes peer-reviewed evidence, mechanism-level reasoning, and clear distinction between established findings and emerging hypotheses.

Every editorial layer is designed to make references traceable, claims contextualized, and clinical interpretation responsible.

The objective is scientific clarity: structured knowledge that supports researchers, formulators, clinicians, and serious learners.

Newsletter / Updates

Quiet research updates

Occasional publication notes and index updates with no aggressive cadence.